<DOC>
<DOCNO>
EP-0010735
</DOCNO>
<TEXT>
<DATE>
19800514
</DATE>
<IPC-CLASSIFICATIONS>
C07D-498/00 A61K-31/395 C07D-498/18 <main>C07D-498/12</main> A61K-31/535 A61P-35/00 
</IPC-CLASSIFICATIONS>
<TITLE>
maytansinoids, their production and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
takeda chemical industries ltdjp<sep>takeda chemical industries, ltd.<sep>takeda chemical industries, ltd.1-1, doshomachi 4-chomechuo-ku, osakajp<sep>takeda chemical industries, ltd.  <sep>
</APPLICANT>
<INVENTOR>
akimoto hiroshi<sep>miyashita osamu<sep>akimoto, hiroshi<sep>miyashita, osamu<sep>akimoto, hiroshihamakoshien-jutaku 3-208, 1-6 minamikoshien3-chome nishinomiya hyogo 663jp<sep>miyashita, osamu25-403, 2 wakayamadai 2-chomeshimamoto-cho mishima-gun, osaka, 618jp<sep>akimoto, hiroshi<sep>miyashita, osamu<sep>akimoto, hiroshihamakoshien-jutaku 3-208, 1-6 minamikoshien3-chome nishinomiya hyogo 663jp<sep>miyashita, osamu25-403, 2 wakayamadai 2-chomeshimamoto-cho mishima-gun, osaka, 618jp<sep>
</INVENTOR>
<ABSTRACT>
novel maytansionoids of the formula:    wherein   r is an alicyclic hydrocarbon group of 3 to 10 carbon  atoms, phenyl or heterocyclic group, which may optionally  be substituted, and   a is an alkylene group of 1 to 4 carbon atoms or a bond,  provided that a means said alkylene group when attached to  a n atom in said heterocyclic group r, e. g.  maytansinol 3-Â­ cyclohexanecarboxylate, have antimitotic and antitumor  activities, and are of value as medicines.  pharmaceutical  compositions are described.  a method for producting a compound of the above  formula comprises acylating maytansinol with a carboxylic  acid of the formula:   r-a-cooh,   wherein r and a are as defined above, or a reactive derivate  of said carboxylic acid with respect to the carboxyl function  thereof.  
</ABSTRACT>
</TEXT>
</DOC>
